Society for Endocrinology - a world-leading authority on hormones


Webinar Topics

The Research Skills webinars will be taking place monthly, available to Society members for free. Registration is required to attend the live talk, with each webinar being made available on-demand within the Members' Area

If you are not a member of the Society and wish to access the webinar series, you can apply for membership by visiting the membership page.

For information on how to access the webinars please visit the general information page.

The topics to be covered are:

Speaker: Aneika Leney (Birmingham)

Aneika Leney obtained a BSc in Biochemistry at the University of York, during which she spends a year in the industry working for GlaxoSmithKline. Aneika then joined Professors Sheena Radford and Alison Ashcroft’s lab in the Astbury Centre, University of Leeds, where she completed her PhD in Biological Mass Spectrometry. Her research focussing on amyloid assembly, bacterial pilus assembly and the development of novel technologies to monitor membrane proteins. After her studies, Aneika relocated to Canada whereby she joined the Alberta Glycomics centre as a post-doctoral researcher under the supervision of John Klassen. Following this, she moved to Utrecht University in the Netherlands where she took a senior post-doctoral role in the laboratory of Albert Heck in the Netherlands Proteomics Centre. Her research focusing on post-translational modifications and the role they have in modulating protein function.

In 2018, Aneika joined the School of Biosciences at the University of Birmingham to establish her own research group. Her group utilises structural-biology mass spectrometry with their biological interests centred around post-translational modifications and how these alter protein function. In 2019, Aneika was identified as an emerging leader by experts within the field of mass spectrometry; having the potential to become a future leader. To date, she has attracted almost £2million funding primarily through the BBSRC to carry out her research with recent publications in Prot. Natl. Acad. Sci., Chem. and Nature Microbiol.

Host: Mark Turner (Coventry)

Speaker: Dr Juliette Strauss (Liverpool).

Dr Juliette Strauss (Senior Lecturer in Exercise and Health Metabolism) is a member of the Exercise Metabolism and Adaptation Research group within the Research Institute of Sport and Exercise Sciences. She is also a Registered Nutritionist and Associate Member of the Sport & Exercise Nutrition Register.

Juliette’s research focuses on three main areas:

1) The regulation of lipid storage and utilisation. In particular, the investigation of the use of novel training and nutritional interventions to understand regulatory processes in 1) cardiometabolic syndrome and at risk populations (metabolic syndrome, type II diabetes, ageing) and 2) sex differences in regulation of lipid metabolism in healthy, ageing and diseased populations.

2) The use of immunofluorescence microscopy methods and transmission electron microscopy in the investigation of skeletal muscle metabolic processes.

3) The female athlete with a particular focus on optimising the metabolic response to exercise, training and nutritional interventions.

A list of publications can be found here.

Dr Mark Turner is a research fellow in endocrinology and metabolism in the Centre for Sport, Exercise and Life Sciences at Coventry University. Mark’s interests are in diabetes, insulin resistance and NAFLD and how they impact glucose and lipid metabolism of skeletal muscle from the cellular to whole-body level. Mark is a member of the Early Career Steering Group for the Society of Endocrinology.


Speaker: Ms Maria Piggin (London

Host: Dr Ali Abbara (London)

Session Overview:

The involvement of patients and the public in the design and conduct of research is essential in ensuring that research is high quality and relevant to patients. This session will explain the difference between public involvement, public engagement and co-production and give examples of how to involve patients and the public in research in a meaningful way throughout the research cycle. It will also outline some practical considerations for public involvement such as who to involve, how to recruit them and how to reimburse patients and the public appropriately such that they are not disadvantaged by being involved in the research. Relevant resources will be signposted to ensure that attendees are able to conduct high-quality public involvement in preparation for funding applications and throughout research projects.

Dr Ali Abbara is an NIHR Clinician Scientist / Clinical Senior Lecturer / Honorary Consultant in Endocrinology at Imperial College London. He graduated with honours from St Bartholomews’ and the Royal London medical school in 2004. Following an NIHR Academic Clinical Fellowship, he completed a PhD in Reproductive Neuroendocrinology in 2014 supported by a ‘Wellcome Trust Clinical Training Fellowship’. After an NIHR Academic Clinical Lectureship, he received an ‘Imperial Post-doctoral Post-CCT Researcher Fellowship’ and later an ‘NIHR Clinician Scientist Award’ to continue researching clinical applications of hypothalamic neuropeptides. In 2019, he received a ‘Society for Endocrinology Leadership and Development Award’.

Maria Piggin, Partnerships and Training Manager, Imperial Patient Experience Research Centre, Imperial College, London

Maria is the Partnerships and Training Manager within the Patient Experience Research Centre (PERC) sitting within the School of Public Health at Imperial College, London. Her role includes delivering public involvement training and provides public involvement advice and support to the NIHR Imperial Biomedical Research Centre. She is also the PPIE co-lead of the Health Protection Research Unit (HPRU) in Modelling and Health Economics. Maria also established, and is the Chair of, a national support charity for patients with an ultra-rare disease. In this role she engages with patients as well as various stakeholders (on behalf of patients) including NHS England, pharmaceutical companies, NICE and the NHS.

Webinars that are now available to stream within the Members' Area 

Kevin McConway (Open University) and hosted by Caroline Gorvin (Birmingham)

Kevin McConway is Emeritus Professor of Applied Statistics at the Open University. He retired from a full-time position there five years ago, after 36 years of teaching statistics and researching in Bayesian statistical methods and in biological and biomedical applications. He has been a Vice-President of the Royal Statistical Society, and statistical adviser on three of the Society for Endocrinology journals. He also has a long-standing interest in the way statistics are presented and used in the media, and works with the Science Media Centre.

Stream on demand the first webinar within the Members' Area.

Host: Mark Turner (Coventry)

Speaker: Joachim Goedhart (Amsterdam)

Dr Joachim Goedhart is a chemist from training, with a strong interest in biology. His lab develops genetically encoded fluorescent probes and biosensors for quantitative cellular imaging. His long-term goal is to unravel signalling networks in time and space in cells and tissues. 

Dr Mark Turner is a research fellow in endocrinology and metabolism in the Centre for Sport, Exercise and Life Sciences at Coventry University. Mark’s interests are in diabetes, insulin resistance and NAFLD and how they impact glucose and lipid metabolism of skeletal muscle from the cellular to whole-body level. Mark is a member of the Early Career Steering Group for the Society of Endocrinology.

Stream on demand the second webinar within the Members' Area.

Speakers: Angela Taylor (Birmingham) & Lorna Gilligan (Birmingham)

Host: Dr Mark Nixon (Edinburgh)

Dr Lorna C. Gilligan is dedicated to translational scientific research and applying mass spectrometry to elucidate metabolic pathway changes in health and disease. She joined the Steroid Metabolome Analysis Core (SMAC) team in 2016 taking over the running of the GC-MS facility. She also develops novel and high-throughput LC-MS/MS assays for her specialist areas of interest, which are conjugated steroids and cardiotonic steroids.
Lorna obtained a BMedSci in Physiology (2007) followed by an MBChB (2009) in Glasgow, where she stayed to complete her medical foundation training. Wanting to pursue a career in research, she moved to the University of Birmingham achieving an MRes (2012) and graduating with a PhD in oestrogen metabolism and colorectal cancer in 2017

Dr Angela E. Taylor is interested in the development of high sensitivity, high throughput, well-validated mass spectrometry assays for steroid analysis. The application of these assays to answer important clinical questions is critical to her research. She feels the truly translational aspect of the work conducted at the Steroid Metabolome Analysis Core (SMAC) means the work is both analytically enjoyable and socially beneficial. Angela has an analytical chemistry master’s degree from Swansea University (2005). In 2009 she received her PhD from Swansea University investigating steroid metabolism in the human endometrium using mass spectrometry. This was followed by post-doctoral work at the University of Birmingham working for Prof Wiebke Arlt, which cumulated in setting up the SMAC facility in 2016. The SMAC lab now conducts steroid research from wet lab-based projects to clinical trials.

Dr Mark Nixon’s research is centred on the discovery of novel mechanisms that control intracellular glucocorticoid action, and how these become maladaptive or dysregulated in cardiometabolic disease. In particular, his research aims at elucidating the mechanisms underlying glucocorticoid delivery to, and action within, key metabolic tissues in the setting of obesity such as adipose tissue. Mark obtained his PhD studying the role of glucocorticoid metabolism in obesity and inflammation at the University of Edinburgh in 2011, before moving to the University of Texas Health Science in Houston to undertake postdoctoral training. In 2018 he was awarded a BHF Intermediate Research Fellowship for research at the University of Edinburgh to investigate a potential role for corticosteroid-binding globulin cleavage in enhancing glucocorticoid delivery to adipose tissue.

Stream on demand the third webinar within the Members' Area.

Speaker: Dr Linford Briant (Oxford) and host Dr Kate Lines (Oxford)

Dr Linford Briant graduated with an MSc in Mathematics at the University of Bristol in 2009. His masters' project involved investigating simple groups (Galois Theory). He spent a year working at the Centre for Public Health (LJMU, Liverpool) working with Dr Penelope Philips-Howard on The Big Drink Debate. He then began a PhD in Engineering Mathematics/Physiology and Pharmacology (with Prof Alan Champneys/Dr Tony Pickering - University of Bristol). His PhD was using predominantly computational techniques to understand sympathetic overactivity in hypertension.

In November 2015 he began a postdoctoral position with Prof Patrik Rorsman and Prof Blanca Rodriguez investigating alpha-cell dysfunction in diabetes. He was awarded his Sir Henry Wellcome Postdoctoral Fellowship shortly after. During his fellowship, he used both computational and experimental techniques to understand which electrophysiological properties of alpha-cells are important for driving glucagon secretion, and how these may contribute to the impaired glucagon secretion seen in diabetes.

Dr Kate Lines is a BMS Research Fellow at the University of Oxford. Previously she was a postdoctoral research scientist in Professor Rajesh Thakker’s laboratory at the Oxford Centre for Endocrinology and Metabolism, University of Oxford, where she is still based. Prior to this, she obtained her PhD from The Barts Cancer Institute, Queen Mary University of London. Her research is focused on understanding the epigenetic mechanisms involved in neuroendocrine tumour development, and using this information to develop new diagnostic approaches and therapies. In particular, she is interested in pancreatic and pituitary tumours caused by loss of the tumour suppressor protein menin. Her research involves studying the epigenetic landscape of these tumours to increase understanding of their epigenetic alterations and investigating small molecule inhibitors of epigenetic modifying proteins to determine their efficacy at reducing tumour cell proliferation in vitro, and tumour growth in vivo, with the aim of taking successful candidates into patients. She is also the Science Convenor of the Society for Endocrinology Endocrine Cancer Network.

Stream on demand the fourth webinar within the Members' Area.

Speaker: Dr Eline Koers (Nottingham) 

Host: Dr Caroline Gorvin (Birmingham)

Dr Koers started her career as an NMR specialist studying membrane proteins. She then branched out to study protein folding using single-molecule force spectroscopy. Recently, she started to focus on membrane protein folding, in particular GPCRs.

Caroline obtained her BSc (Hons) in Biomedical Science with Industrial Experience in 2008 from the University of Manchester. She spent her year in industry in 2007 at AstraZeneca plc in the in vitro electrophysiology team. Caroline then moved to the University of Oxford for her PhD studies, where her research focussed on the cellular mechanisms by which mutations in a chloride-proton antiporter cause the renal disorder Dent’s disease. She also spent time on secondment at UMC St Radboud, Nijmegen, The Netherlands, during this period.
Caroline continued in Oxford undertaking postdoctoral research investigating the signalling and trafficking of the GPCR, calcium-sensing receptor, and its role in calcium homeostasis. Caroline moved to the IMSR in January 2018 to establish her research group investigating metabolic GPCRs.